IBDEI04Z ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6134,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,6134,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,6135,0)
 ;;=E16.2^^26^394^29
 ;;^UTILITY(U,$J,358.3,6135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6135,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,6135,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,6135,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,6136,0)
 ;;=E20.0^^26^394^34
 ;;^UTILITY(U,$J,358.3,6136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6136,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,6136,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,6136,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,6137,0)
 ;;=E20.9^^26^394^30
 ;;^UTILITY(U,$J,358.3,6137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6137,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,6137,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,6137,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,6138,0)
 ;;=E23.0^^26^394^31
 ;;^UTILITY(U,$J,358.3,6138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6138,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,6138,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,6138,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,6139,0)
 ;;=E27.1^^26^394^51
 ;;^UTILITY(U,$J,358.3,6139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6139,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,6139,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,6139,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,6140,0)
 ;;=E27.2^^26^394^1
 ;;^UTILITY(U,$J,358.3,6140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6140,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,6140,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,6140,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,6141,0)
 ;;=E27.3^^26^394^23
 ;;^UTILITY(U,$J,358.3,6141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6141,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,6141,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,6141,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,6142,0)
 ;;=E29.1^^26^394^52
 ;;^UTILITY(U,$J,358.3,6142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6142,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,6142,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,6142,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,6143,0)
 ;;=E55.9^^26^394^59
 ;;^UTILITY(U,$J,358.3,6143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6143,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,6143,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,6143,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,6144,0)
 ;;=E66.01^^26^394^38
 ;;^UTILITY(U,$J,358.3,6144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6144,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,6144,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,6144,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,6145,0)
 ;;=E66.8^^26^394^42
 ;;^UTILITY(U,$J,358.3,6145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6145,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,6145,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,6145,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,6146,0)
 ;;=E66.9^^26^394^43
 ;;^UTILITY(U,$J,358.3,6146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6146,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,6146,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,6146,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,6147,0)
 ;;=E74.39^^26^394^35
 ;;^UTILITY(U,$J,358.3,6147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6147,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,6147,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,6147,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,6148,0)
 ;;=E83.30^^26^394^46
 ;;^UTILITY(U,$J,358.3,6148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6148,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,6148,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,6148,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,6149,0)
 ;;=E83.51^^26^394^28
 ;;^UTILITY(U,$J,358.3,6149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6149,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,6149,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,6149,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,6150,0)
 ;;=E83.52^^26^394^26
 ;;^UTILITY(U,$J,358.3,6150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6150,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,6150,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,6150,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,6151,0)
 ;;=E87.5^^26^394^27
 ;;^UTILITY(U,$J,358.3,6151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6151,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,6151,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,6151,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,6152,0)
 ;;=E89.2^^26^394^48
 ;;^UTILITY(U,$J,358.3,6152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6152,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,6152,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,6152,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,6153,0)
 ;;=E89.6^^26^394^47
 ;;^UTILITY(U,$J,358.3,6153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6153,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,6153,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,6153,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,6154,0)
 ;;=L68.0^^26^394^25
 ;;^UTILITY(U,$J,358.3,6154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6154,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,6154,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,6154,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,6155,0)
 ;;=M80.00XA^^26^394^2
 ;;^UTILITY(U,$J,358.3,6155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6155,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,6155,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,6155,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,6156,0)
 ;;=M81.0^^26^394^3
 ;;^UTILITY(U,$J,358.3,6156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6156,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,6156,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,6156,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,6157,0)
 ;;=M85.80^^26^394^44
 ;;^UTILITY(U,$J,358.3,6157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6157,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,6157,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,6157,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,6158,0)
 ;;=N62.^^26^394^24
 ;;^UTILITY(U,$J,358.3,6158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6158,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,6158,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,6158,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,6159,0)
 ;;=E10.43^^26^394^6
 ;;^UTILITY(U,$J,358.3,6159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6159,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,6159,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,6159,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,6160,0)
 ;;=E10.59^^26^394^4
 ;;^UTILITY(U,$J,358.3,6160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6160,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,6160,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,6160,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,6161,0)
 ;;=E10.618^^26^394^5
 ;;^UTILITY(U,$J,358.3,6161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6161,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,6161,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,6161,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,6162,0)
 ;;=E10.621^^26^394^7
 ;;^UTILITY(U,$J,358.3,6162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6162,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,6162,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,6162,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,6163,0)
 ;;=E10.622^^26^394^11
 ;;^UTILITY(U,$J,358.3,6163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6163,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,6163,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,6163,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,6164,0)
 ;;=E10.65^^26^394^10
 ;;^UTILITY(U,$J,358.3,6164,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6164,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,6164,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,6164,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,6165,0)
 ;;=E10.39^^26^394^9
 ;;^UTILITY(U,$J,358.3,6165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6165,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,6165,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,6165,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,6166,0)
 ;;=E66.3^^26^394^45
 ;;^UTILITY(U,$J,358.3,6166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6166,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,6166,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,6166,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,6167,0)
 ;;=E89.1^^26^394^49
 ;;^UTILITY(U,$J,358.3,6167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6167,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,6167,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,6167,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,6168,0)
 ;;=H40.9^^26^395^9
 ;;^UTILITY(U,$J,358.3,6168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6168,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,6168,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,6168,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,6169,0)
 ;;=H26.9^^26^395^5
 ;;^UTILITY(U,$J,358.3,6169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6169,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,6169,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,6169,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,6170,0)
 ;;=H10.9^^26^395^8
 ;;^UTILITY(U,$J,358.3,6170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6170,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,6170,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,6170,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,6171,0)
 ;;=H11.32^^26^395^6
 ;;^UTILITY(U,$J,358.3,6171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6171,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,6171,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,6171,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,6172,0)
 ;;=H11.31^^26^395^7
